Cappellari, Manuel http://orcid.org/0000-0002-3534-3201
Saia, Valentina
Pracucci, Giovanni
Casetta, Ilaria
Fainardi, Enrico
Sallustio, Fabrizio
Ruggiero, Maria
Romoli, Michele
Simonetti, Luigi
Zini, Andrea
Lazzarotti, Guido Andrea
Orlandi, Giovanni
Vallone, Stefano
Bigliardi, Guido
Renieri, Leonardo
Nencini, Patrizia
Semeraro, Vittorio
Boero, Giovanni
Bracco, Sandra
Tassi, Rossana
Castellano, Davide
Naldi, Andrea
Biraschi, Francesco
Nicolini, Ettore
Del Sette, Bruno
Malfatto, Laura
Allegretti, Luca
Tassinari, Tiziana
Tessitore, Agostino
Ferraù, Ludovica
Saletti, Andrea
De Vito, Alessandro
Lafe, Elvis
Cavallini, Anna
Bergui, Mauro
Bosco, Giovanni
Feraco, Paola
Bignamini, Valeria
Mandruzzato, Nicolò
Vit, Federica
Mardighian, Dikran
Magoni, Mauro
Comelli, Simone
Melis, Maurizio
Menozzi, Roberto
Scoditti, Umberto
Cester, Giacomo
Viario, Federica
Stecco, Alessandro
Fleetwood, Thomas
Filauri, Pietro
Sacco, Simona
Giorgianni, Andrea
Cariddi, Lucia Princiotta
Piano, Mariangela
Motto, Cristina
Gallesio, Ivan
Sepe, Federica
Romano, Giuseppe
Grasso, Maria Federica
Lozupone, Emilio
Fasano, Antonio
Comai, Alessio
Franchini, Erica
Bruni, Stefano
Silvestrini, Mauro
Chiumarulo, Luigi
Petruzzelli, Marco
Pavia, Marco
Invernizzi, Paolo
Puglielli, Edoardo
Casalena, Alfonsina
Pedicelli, Alessandro
Frisullo, Giovanni
Amistà, Pietro
Russo, Monia
Allegritti, Massimiliano
Caproni, Stefano
Mangiafico, Salvatore
Toni, Danilo
,
Article History
Accepted: 3 June 2023
First Online: 28 June 2023
Declarations
:
: MC: consultancy or advisory board fees or speaker’s honoraria from Boehringer Ingelheim, Pfizer/Bristol Meyer Squibb, and Daiichi Sankyo. AZ: consultancy and speaker’s honoria fees from Boehringer-Ingelheim, Medtronic, Cerenovus and advisory board from Daiichi Sankyo and Boehringer-Ingelheim and Stryker. LR: speaker’s honoraria from stryker, penumbra. EL: consultancy fees from Stryker. ADV: consultancy from Boehringer Ingelheim, Daichi Sankyo. MB: consultancy fees from Stryker, Penumbra. SC: advisory board fees or speaker’s honoraria from Abbott, Allergan-Abbvie, AstraZeneca, Eli Lilly, Lundbeck, Novartis, NovoNordisk, Pfizer, Teva. All other authors report no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The present study was in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Need for ethical approval or patient consent for participation in the IRETAS varied among participating hospitals. Informed consent to use of anonymized and aggregated data for participation in the IRETAS was obtained in all patients of each center.